The study looked at 12,370 people with Parkinson's disease and more than 1.2 million people without the disease.

A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.

A common chemical that is widespread in the U.S. has been linked to an increased risk of Parkinson’s disease, researchers say. In a recent study published in the journal Neurology, researchers found a ...

Parkinson's diagnoses are going up in Kansas and Missouri. According to recent research, Kansas and Missouri rank among the ...

Parkinson’s disease — which can cause tremors, slow movement and stiffness — is believed to affect 1 in every 336 Americans. The exact cause of the neurodegenerative disorder is not known, but it is ...

EDITOR’S NOTE: The podcast Chasing Life With Dr. Sanjay Gupta explores the medical science behind some of life’s mysteries big and small. You can listen to episodes here. The “Shaking Palsy.” Those ...

As the global population ages, the prevalence of Parkinson’s continues to rise, with an estimated 25 million people expected to be living with the neurological disease by 2050. The incurable ...

Fox Foundation for Parkinson's Research (MJFF) announces the arrival of the national event series "Parkinson's IQ + You" to Southern Nevada. Since 2019, Parkinson's IQ + You events have traveled to 23 ...

Learn about progressive supranuclear palsy (PSP), a rare brain disorder affecting body movements, balance, and eye movements.

A new study from Chalmers University of Technology in Sweden, along with Oslo University Hospital in Norway, may have discovered a way to detect biomarkers of Parkinson’s disease in the blood up to ...